HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Sanofi and Boehringer enter discussions to swap key businesses; Boehringer would pay €4.7bn cash; definitive agreement signed

Executive Summary

Sanofi and Boehringer Ingelheim GMBH entered into exclusive discussions surrounding the swap of key businesses that could make Sanofi the number one consumer health care (CHC) firm in the world and help Boehringer become the second largest animal health company globally.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Cash

Related Companies